XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Restricted Stock Units
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Common Stock
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Additional Paid-in Capital
Restricted Stock Units
Additional Paid-in Capital
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Revision of Prior Period, Accounting Standards Update, Adjustment [Member]
Beginning balance (in shares) at Feb. 06, 2022       292,633              
Beginning balance at Feb. 06, 2022 $ 754,336   $ (35,127) $ 29   $ 2,470,943   $ (133,265) $ (8,365) $ (1,708,271) $ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       1,233              
Issuance of common stock upon exercise of stock options 11,433         11,433          
Stock-based compensation expense 75,685         75,685          
Vesting of restricted stock units (in shares)         3,608            
Vesting of restricted stock units   $ 0     $ 1   $ (1)        
Tax withholding on vesting of equity awards and restricted stock units (in shares)       (295)              
Tax withholding on vesting of equity awards and restricted stock units (10,194)         (10,194)          
Common stock issued under employee stock purchase plan (in shares)       2,087              
Common stock issued under employee stock purchase plan 19,396         19,396          
Repurchases of common stock (in shares)       (2,134)              
Repurchases of common stock (66,420)         (66,420)          
Other comprehensive (loss) income (10,480)               (10,480)    
Net loss (11,535)                 (11,535)  
Ending balance (in shares) at May. 08, 2022       297,132              
Ending balance at May. 08, 2022 727,094     $ 30   2,367,577     (18,845) (1,621,668)  
Beginning balance (in shares) at Feb. 05, 2023       304,076              
Beginning balance at Feb. 05, 2023 941,233     $ 30   2,493,769     (15,504) (1,537,062)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)       790              
Issuance of common stock upon exercise of stock options 4,619         4,619          
Stock-based compensation expense 78,665         78,665          
Vesting of restricted stock units (in shares)         3,670            
Vesting of restricted stock units   0     $ 1   (1)        
Tax withholding on vesting of equity awards and restricted stock units (in shares)         (281)            
Tax withholding on vesting of equity awards and restricted stock units   $ (6,759)         $ (6,759)        
Common stock issued under employee stock purchase plan (in shares)       1,069              
Common stock issued under employee stock purchase plan 21,219         21,219          
Repurchases of common stock (in shares)       (2,872)              
Repurchases of common stock (69,911)         (69,911)          
Issuance of common stock upon conversion of convertible senior notes (in shares)       1              
Issuance of common stock upon conversion of convertible senior notes (456)         (456)          
Other comprehensive (loss) income 4,598               4,598    
Net loss (67,401)                 (67,401)  
Ending balance (in shares) at May. 07, 2023       306,453              
Ending balance at May. 07, 2023 $ 905,807     $ 31   $ 2,521,145     $ (10,906) $ (1,604,463)